The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Inhibition of amyloid-β aggregation and caspase-3 activation by the Ginkgo biloba extract EGb761
Open accessAbstract
Standardized extract from the leaves of the Ginkgo biloba tree, labeled EGb761, has been used in clinical trials for its beneficial effects on brain functions, particularly in connection with age-related dementias and Alzheimer's disease (AD). Substantial experimental evidence indicates that EGb761 protects against neuronal damage from a variety of insults, but its cellular and molecular mechanisms remain unknown. Using a neuroblastoma cell line stably expressing an AD-associated double mutation, we report that EGb761 inhibits formation of amyloid-β (Aβ) fibrils, which are the diagnostic, and possibly causative, feature of AD. The decreased Aβ fibrillogenesis in the presence of EGb761 was observed both in the conditioned medium of this Aβ-secreting cell line and in solution in vitro . In the cells, EGb761 significantly attenuated mitochondrion-initiated apoptosis and decreased the activity of caspase 3, a key enzyme in the apoptosis cell-signaling cascade. These results suggest that ( i ) neuronal damage in AD might be due to two factors: a direct Aβ toxicity and the apoptosis initiated by the mitochondria; and ( ii ) multiple cellular and molecular neuroprotective mechanisms, including attenuation of apoptosis and direct inhibition of Aβ aggregation, underlie the neuroprotective effects of EGb761.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Green, D. R., & Reed, J. C. (1998) · Science · doi:10.1126/science.281.5381.1309 · Cited by 8,965
Thornberry, N. A., & Lazebnik, Y. (1998) · Science · doi:10.1126/science.281.5381.1312 · Cited by 6,887
Induction of Apoptotic Program in Cell-Free Extracts: Requirement for dATP and Cytochrome c
Liu, X., Kim, C. N., Yang, J., Jemmerson, R., & Wang, X. (1996) · Cell · doi:10.1016/s0092-8674(00)80085-9 · Cited by 5,167
Control of inositol 1,4,5-trisphosphate-induced Ca2+ release by cytosolic Ca2+
Bootman, M. D., Missiaen, L., Parys, J. B., De Smedt, H., & Casteels, R. (1995) · Biochemical Journal · doi:10.1042/bj3060445 · Cited by 5,120
Mutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837
Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-β
Nakagawa, T., Zhu, H., Morishima, N., Li, E., Xu, J., Yankner, B. A., & Yuan, J. (2000) · Nature · doi:10.1038/47513 · Cited by 3,256
Biochemical Pathways of Caspase Activation During Apoptosis
Budihardjo, I., Oliver, H., Lutter, M., Luo, X., & Wang, X. (1999) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.15.1.269 · Cited by 2,565
Neurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin Neuropeptides
Yankner, B. A., Duffy, L. K., & Kirschner, D. A. (1990) · Science · doi:10.1126/science.2218531 · Cited by 1,975
A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity
Weggen, S., Eriksen, J. L., Das, P., Sagi, S. A., Wang, R., Pietrzik, C. U., Findlay, K. A., Smith, T. E., Murphy, M. P., Bulter, T., et al. (2001) · Nature · doi:10.1038/35102591 · Cited by 1,388
Endoproteolysis of Presenilin 1 and Accumulation of Processed Derivatives In Vivo
Thinakaran, G., Borchelt, D. R., Lee, M. K., Slunt, H. H., Spitzer, L., Kim, G., Ratovitsky, T., Davenport, F., Nordstedt, C., Seeger, M., et al. (1996) · Neuron · doi:10.1016/s0896-6273(00)80291-3 · Cited by 1,013
Mechanisms of Neuronal Degeneration in Alzheimer's Disease
Yankner, B. A. (1996) · Neuron · doi:10.1016/s0896-6273(00)80115-4 · Cited by 955
Soto, C., Sigurdsson, E. M., Morelli, L., Asok Kumar, R., Castaño, E. M., & Frangione, B. (1998) · Nature Medicine · doi:10.1038/nm0798-822 · Cited by 876
Hartley, D. M., Walsh, D. M., Ye, C. P., Diehl, T., Vasquez, S., Vassilev, P. M., Teplow, D. B., & Selkoe, D. J. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-20-08876.1999 · Cited by 817
MUTANT GENES IN FAMILIAL ALZHEIMER'S DISEASE AND TRANSGENIC MODELS
Price, D. L., & Sisodia, S. S. (1998) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.21.1.479 · Cited by 572
Arispe, N., Pollard, H. B., & Rojas, E. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.22.10573 · Cited by 557
Kokoszka, J. E., Coskun, P., Esposito, L. A., & Wallace, D. C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051627098 · Cited by 492
Ginkgo Biloba Extract (EGb 761) and CNS Functions Basic Studies and Clinical Applications
DeFeudis, F., & Drieu, K. (2000) · Current Drug Targets · doi:10.2174/1389450003349380 · Cited by 441
Stadelmann, C., Deckwerth, T. L., Srinivasan, A., Bancher, C., Brück, W., Jellinger, K., & Lassmann, H. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65460-0 · Cited by 428
Snyder, S. W., Ladror, U. S., Wade, W. S., Wang, G. T., Barrett, L. W., Matayoshi, E. D., Huffaker, H. J., Krafft, G. A., & Holzman, T. F. (1994) · Biophysical Journal · doi:10.1016/s0006-3495(94)80591-0 · Cited by 381
Caspase-2 Mediates Neuronal Cell Death Induced by β-Amyloid
Troy, C. M., Rabacchi, S. A., Friedman, W. J., Frappier, T. F., Brown, K., & Shelanski, M. L. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-04-01386.2000 · Cited by 354
Inhibition of Alzheimer β-Fibrillogenesis by Melatonin
Pappolla, M., Bozner, P., Soto, C., Shao, H., Robakis, N. K., Zagorski, M., Frangione, B., & Ghiso, J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.13.7185 · Cited by 337
Xu, H., Sweeney, D., Wang, R., Thinakaran, G., Lo, A. C. Y., Sisodia, S. S., Greengard, P., & Gandy, S. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.8.3748 · Cited by 282
Self-citationAmyloid β-peptide induces apoptosis-related events in synapses and dendrites
Mattson, M. P., Partin, J., & Begley, J. G. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00763-x · Cited by 259
The in vivo neuromodulatory effects of the herbal medicine ginkgo biloba
Watanabe, C. M. H., Wolffram, S., Ader, P., Rimbach, G., Packer, L., Maguire, J. J., Schultz, P. G., & Gohil, K. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111126298 · Cited by 234
Yao, Z.-X., Drieu, K., & Papadopoulos, V. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03131-0 · Cited by 181
Anti-apoptotic properties of Ginkgo biloba extract EGb 761 in differentiated PC12 cells.
Smith, J. V., Burdick, A. J., Golik, P., Khan, I. A., Wallace, D. C., & Luo, Y. (2002) · PubMed · Cited by 84
Self-citationSeries Introduction: Alzheimer’s disease: perspectives for the new millennium
Sisodia, S. S. (1999) · Journal of Clinical Investigation · doi:10.1172/jci8508 · Cited by 82
Amyloid-β Interactions with Chondroitin Sulfate-derived Monosaccharides and Disaccharides
Fraser, P. E., Darabie, A. A., & McLaurin, J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008128200 · Cited by 78
Ginkgo biloba neuroprotection: Therapeutic implications in Alzheimer's disease
Luo, Y. (2001) · Journal of Alzheimer s Disease · doi:10.3233/jad-2001-3407 · Cited by 76
Self-citationOxidation of Aβ and Plaque Biogenesis in Alzheimer's Disease and Down Syndrome
Head, E., Garzon-Rodriguez, W., Johnson, J. K., Lott, I. T., Cotman, C. W., & Glabe, C. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0431 · Cited by 75
Blanchard, B. J., Konopka, G., Russell, M., & Ingram, V. M. (1997) · Brain Research · doi:10.1016/s0006-8993(97)01003-2 · Cited by 72
Tsuzuki, K., Fukatsu, R., Yamaguchi, H., Tateno, M., Imai, K., Fujii, N., & Yamauchi, T. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)00834-x · Cited by 72
Sanderson, K. L., Butler, L. D., & Ingram, V. M. (1997) · Brain Research · doi:10.1016/s0006-8993(96)01060-8 · Cited by 67
New Leads on the 'How' of Alzheimer's
Marx, J. L. (2001) · Science · doi:10.1126/science.293.5538.2192 · Cited by 63
Kurita‐Ochiai, T., Ochiai, K., & Fukushima, K. (2001) · Clinical and Diagnostic Laboratory Immunology · doi:10.1128/cdli.8.2.325-332.2001 · Cited by 52
[29] Screening for pharmacologic inhibitors of amyloid fibril formation
LeVine, H., & Scholten, J. D. (1999) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(99)09031-x · Cited by 43
APP processing, Aβ-amyloidogenesis, and the pathogenesis of Alzheimer's disease
Gandy, S., Caporaso, G. L., Buxbaum, J. D., Frangione, B., & Greengard, P. (1994) · Neurobiology of Aging · doi:10.1016/0197-4580(94)90125-2 · Cited by 39
Cited by
Amyloid Beta: Structure, Biology and Structure-Based Therapeutic Development
Chen, G.-F., Xu, T.-H., Yan, Y., Zhou, Y.-R., Jiang, Y., Melcher, K., & Xu, H. E. (2017) · Acta Pharmacologica Sinica · doi:10.1038/aps.2017.28 · Cited by 1,965
Self-citationDeciphering the Molecular Basis of Memory Failure in Alzheimer's Disease
Walsh, D. M., & Selkoe, D. J. (2004) · Neuron · doi:10.1016/j.neuron.2004.09.010 · Cited by 1,207
Polyphenols and Human Health: Prevention of Disease and Mechanisms of Action
Vauzour, D., Rodriguez-Mateos, A., Corona, G., Oruna-Concha, M. J., & Spencer, J. P. E. (2010) · Nutrients · doi:10.3390/nu2111106 · Cited by 855
Ramassamy, C. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.06.025 · Cited by 682
Buendia, I., Michalska, P., Navarro, E., Gameiro, I., Egea, J., & León, R. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.11.003 · Cited by 678
Metadata
- Authors
- Luo, Y., Smith, J. V., Paramasivam, V., Burdick, A., Curry, K. J., Buford, J. P., Khan, I., Netzer, W. J., Xu, H., & Butko, P.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2002-09-04
- Volume
- 99
- Issue
- 19
- Pages
- 12197-12202
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2015004507
- Cited by
- 398
- References
- 37
- FWCI
- 33.55
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.